Video Experimental Relacionado
Updated: Jun 29, 2026
08:27
Non-Invasive Model of Neuropathogenic Escherichia coli Infection in the Neonatal Rat
Published on: October 29, 2014
La meningitis bacteriana en niños
Xavier Sáez-Llorens1, George H McCracken
1University of Panama School of Medicine, Hospital del Niño, Panama City, Panama. xsaezll@cwpanama.net
Lancet (London, England)
|June 27, 2003
Resumen
La meningitis bacteriana es rara en las naciones desarrolladas, pero devastadora en los países en desarrollo. La investigación es crucial para nuevos tratamientos y la implementación de vacunas en todo el mundo para prevenir esta infección.
Área de la Ciencia:
- Enfermedades infecciosas pediátricas.
- Microbiología Microbiología.
- Epidemiología La epidemiología.
Sus antecedentes:
- Se revisa la epidemiología, microbiología, fisiopatología, manifestaciones clínicas, diagnóstico, manejo, pronóstico y prevención de la meningitis bacteriana, centrándose en los casos pediátricos.
- Los cambios en el panorama de la meningitis bacteriana incluyen una reducción de Haemophilus influenzae, el emergente Streptococcus pneumoniae resistente a los antibióticos y un aumento de los brotes de Neisseria meningitidis.
- Se está llevando a cabo una investigación significativa para las vacunas conjugadas contra la meningitis neumocócica y meningocócica.
Objetivo del estudio:
- Proporcionar una revisión completa de la meningitis bacteriana, haciendo hincapié en la población pediátrica.
- Para resaltar los desafíos en evolución y las direcciones de investigación en la meningitis bacteriana.
Principales métodos:
- Revisión de la literatura que abarca la epidemiología, microbiología, fisiopatología, aspectos clínicos, diagnóstico, gestión, pronóstico y prevención.
- Análisis de las tendencias recientes, incluida la resistencia a los antibióticos, el desarrollo de vacunas y las disparidades mundiales.
Principales resultados:
- La meningitis bacteriana es ahora poco común en los países desarrollados, pero sigue siendo una grave amenaza en los países en desarrollo.
- La aparición de neumococos multirresistentes y tolerantes a la vancomicina, junto con brotes de meningocócicos, presenta desafíos continuos.
- El desarrollo de vacunas conjugadas para la meningitis neumocócica y meningocócica es prometedor.
Conclusiones:
- A pesar de los avances, la meningitis bacteriana requiere una investigación básica y clínica continua para nuevos agentes antimicrobianos y antiinflamatorios.
- La distribución global y la implementación de vacunas efectivas son esenciales para prevenir la meningitis bacteriana en todo el mundo.
Videos de Conceptos Relacionados
01:24Bacterial Meningitis
Bacterial meningitis is a severe infectious disease involving inflammation of the meninges, the protective membranes surrounding the brain and spinal cord. It occurs when pathogenic bacteria cross the blood–brain barrier and enter the cerebrospinal fluid. Common causative organisms include Neisseria meningitidis, Streptococcus pneumoniae, Haemophilus influenzae type b, Listeria monocytogenes, and Escherichia coli K1. The exact route of entry varies by pathogen and host condition.Routes of Entry...
01:18Viral Meningitis
Viral meningitis is the most common form of meningitis and is often referred to as aseptic meningitis to indicate the absence of bacterial involvement. It is generally milder than bacterial meningitis, with symptoms including fever, headache, stiff neck, drowsiness, nausea, photophobia, and vomiting. Rarely, more severe manifestations or death may occur. Common causative agents include enteroviruses, particularly coxsackie A and B viruses and echoviruses, all members of the Enterovirus genus...
01:27Cryptococcal Meningitis
Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
01:22Bacterial Meningitis I: Introduction
Bacterial meningitis is a severe, life-threatening inflammation of the meninges, particularly the pia mater and arachnoid mater, affecting the subarachnoid space, ventricles, and cerebrospinal fluid (CSF). If untreated, it can lead to significant neurological complications or death.Causative AgentsCommon pathogens vary with age and immune status. In adults, major organisms include Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae. Streptococcus agalactiae (group B...
01:26Bacterial Meningitis II: Pathophysiology
Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...
01:19Encephalitis l: Introduction
Encephalitis is inflammation of the brain parenchyma, most often due to infections or autoimmune processes. It presents with neuropsychiatric features such as fever, altered mental status, behavioral changes, cognitive dysfunction, seizures, focal deficits, and sometimes autonomic instability. In some cases, the meninges are also involved, resulting in meningoencephalitis.Infectious CausesInfectious encephalitis is most commonly viral but can also result from bacterial, fungal, or parasitic...